Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials

摘要

BackgroundThe US FDA recently developed CD3+, a counterfeit detection tool that is based on sample illumination at specific wavelengths of light and visual comparison of suspect sample and packaging materials to an authentic sample. To test performance of the CD3+ in field conditions, a study was conducted in Ghana which compared the CD3+ side-by-side with two existing medicine quality screening technologies—TruScan™ Portable Raman spectrometer and GPHF Minilab^®.